Does CERITINIB Cause Malignant neoplasm progression? 523 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 523 reports of Malignant neoplasm progression have been filed in association with CERITINIB (ZYKADIA). This represents 18.7% of all adverse event reports for CERITINIB.
523
Reports of Malignant neoplasm progression with CERITINIB
18.7%
of all CERITINIB reports
196
Deaths
156
Hospitalizations
How Dangerous Is Malignant neoplasm progression From CERITINIB?
Of the 523 reports, 196 (37.5%) resulted in death, 156 (29.8%) required hospitalization, and 20 (3.8%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CERITINIB. However, 523 reports have been filed with the FAERS database.
What Other Side Effects Does CERITINIB Cause?
Diarrhoea (452)
Death (391)
Nausea (381)
Vomiting (270)
Metastases to central nervous system (203)
Non-small cell lung cancer (183)
Fatigue (149)
Decreased appetite (139)
Dyspnoea (137)
Disease progression (116)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which CERITINIB Alternatives Have Lower Malignant neoplasm progression Risk?
CERITINIB vs CERLIPONASE ALFA
CERITINIB vs CERTICAN
CERITINIB vs CERTOLIZUMAB
CERITINIB vs CERTOLIZUMAB PEGOL
CERITINIB vs CERTOPARIN